Lisinopril prevents bullous pemphigoid induced by dipeptidyl peptidase 4 inhibitors via the mas receptor pathway

HIGHLIGHTS

• who: Keisuke Nozawa and colleagues from the Universitu00e0 del Piemonte Orientale, Italy University of Eastern Piedmont, Italy have published the article: Lisinopril prevents bullous pemphigoid induced by dipeptidyl peptidase 4 inhibitors via the Mas receptor pathway, in the Journal: (JOURNAL)
• what: The authors focused on MMP9 production by monocytes and macrophages using hPBMCs. The authors used adverse event data from the FAERS database, on the basis of which several unexpected drug-drug interactions were identified as confounding factors .
• how: Data were collected using FACSDiva software (BD Biosciences) and were analyzed using FlowJo 10 . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.